The Rising Threat of Antimicrobial Resistance: What Happens When Diseases Resist the Drugs We’ve Designed to Fight Them?

Join MSH, in conjunction with the office of Congressman Ami Bera (D-CA), for an important discussion on the rising threat of antimicrobial resistance (AMR) and what we can do to stop it, Tuesday, July 16 from 8:30 to 10:30 am on Capitol Hill.

AMR is one of the most pressing global health threats of our time—in poor and wealthy nations alike. 

Each year, more than 700,000 people die from AMR-related infections. One-third of these deaths are from multidrug-resistant tuberculosis alone, a figure that experts predict could rise to 10 million deaths globally per year by 2050 if no action is taken. 

This May, the Interagency Coordination Group on Antimicrobial Resistance released its report to the Secretary-General of the United Nations, stating that approximately 2.4 million people in high-income countries could die between 2015 and 2050 without a sustained effort to contain AMR. Unabated, untold catastrophic damage could occur to the global economy. 

The second event in our health security breakfast series, this discussion will focus on the rising threat of AMR; the consequences that the world—and the US in particular—face if it is left unchecked; and additional efforts, investments, and incentives needed to fight AMR.